The rapid evolution of generative AI has produced tools capable of creating images, music, and short video clips. But a new class of platforms is beginning to tackle something much more ambitious: ...
Marathon is back after a 30-year hiatus, but how does it play? We give you the lowdown on its graphics, gameplay, and more, fresh off the recent server slam.
It’s time to jump back into the pit. Ball x Pit is one of the very best games of 2025 and there’s now even more to play around with in the brick-busting roguelite. The first major free update for the ...
Twenty-seven states and counting are on track to participate in the first federal program that will direct funds to families so their children can enroll in private schools and cover other expenses ...
The director of the Stranger Things documentary has cast doubt on the fan suggestion that the Duffer brothers might have used ChatGPT to write their scripts. Martina Radwan’s Stranger Things ...
A Hudson County doctor was indicted on 58 counts in December, including charges of exchanging opioids for sexual favors, medical fraud and running a drug-involved premises, federal prosecutors said.
The state of Utah is allowing artificial intelligence to prescribe medication refills to patients without direct human oversight in a pilot program public advocates call “dangerous.” The program is ...
Performances in N.Y.C. The actor also stars in the Off Broadway production of “This World of Tomorrow,” a yearslong project at the Shed through Dec. 21. The actor also stars in the Off Broadway ...
China’s electric vehicle market isn’t just growing, it’s evolving faster than most can process. With new models rolling out at breakneck speed, the country’s automakers aren’t simply keeping pace with ...
INDIANAPOLIS — On Tuesday, Indiana Gov. Mike Braun touted the launch of "Family First Workplace," a new initiative that allows state employees to bring their infants up to six months old to work. It ...
Regeneron is adding its name to Tessera Therapeutics’ unique in vivo gene-writing program, inking a deal that lets it in on a prospect for alpha-1 antitrypsin deficiency (AATD) through a $150 million ...